• 

  Poonawalla urges world to be patient; says Serum directed to prioritise India needs

  India | February 21, 2021 11:50 IST

  India has already provided over 229 lakh doses of coronavirus vaccines to various countries out of which 64 lakh doses have been supplied as grant assistance and 165 lakh on commercial basis.

• 

  Success Story of Cyrus Poonawalla: The man behind India's prestigious Serum Institute of India

  News | February 03, 2021 22:23 IST

  Cyrus Poonawalla was born in a family that had old ties to India racing circuit, through the family Poonawalla Stud Farms. At a young age, Poonawalla realized that since the horse racing had no future in a socialist nation like India, he needed to explore other venues. He realized that creating a product for the masses than for the elite would be a smarter move. The Serum Institute of India was founded by the Poonawalla in 1966, and they launched their first therapeutic tetanus serum within two years and started producing the anti-tetanus vaccines soon after.

• 

  Novavax Vaccine: Hope to launch Covovax by June 2021, says Adar Poonawalla

  India | January 30, 2021 14:26 IST

  Novavax, a vaccine undergoing trials for effectiveness against the novel coronavirus, has become the first immune dose to definitively confirm protection against the new variant of the deadly virus which was detected in the UK late last year.

• 

  Serum Institute fire: Accident or sabotage? Here's what CM Uddhav Thackeray said

  India | January 22, 2021 20:13 IST

  The massive blaze ravaged three to four floors of the upcoming facility in Manjari that was scheduled to become operational within a month or so.

• 

  Serum Institute fire tragedy: 5 killed, 'anguished', says PM Modi; Covishield facility safe

  India | January 21, 2021 21:18 IST

  Serum Institute of India (SII), Pune on Thursday announced a compensation of Rs 25 lakh to each family who have lost their loved ones in the fire incident today.

• 

  4 more Covid vaccines in different stages of trial: Serum Institute of India

  Business | January 17, 2021 12:43 IST

  The SII has partnered with Novavax Inc to manufacture its potential Covid-19 vaccine for India and other countries.

• 

  Super 100: Serum Institute chief Adar Poonawalla takes covid vaccine

  News | January 16, 2021 16:53 IST

  Adar Poonawalla took to Twitter and shared a video on his account of taking the Covishield vaccine himself which has been manufactured by his company.

• 

  SII CEO Adar Poonawalla receives Covid-19 vaccine as nationwide vaccination drive begins

  India | January 16, 2021 14:34 IST

  As nationwide Covid-19 vaccination drive begins, Serum Institute of India (SII) CEO Adar Poonawalla on Saturday received Covid-19 vaccine - Covidshield in Pune.

• 

  'Trying to make everyone happy': Poonawalla says as SII rolls out first consignment of vaccines

  India | January 12, 2021 17:28 IST

  Pune-based Serum Institute of India (SII) on Tuesday rolled out the first consignment of over 56 lakh doses of Covishield vaccine for 13 cities across the country, four days ahead of a massive pan-India inoculation drive against COVID-19.

• 

  'Very safe': Serum Institute's Adar Poonawalla assures as Covishield gets approval

  India | January 03, 2021 19:55 IST

  Serum Institute of India (SII) Chief Executive Officer Adar Poonawalla on Sunday assured that the Covishield vaccine, which has received approval for restricted emergency use, is "very safe".

• 

  Super 100 | Adar Poonawalla thanks PM Modi, DCGI after Covishield gets final approval

  News | January 03, 2021 16:28 IST

  Even before getting the approval from the apex drug controller of India, Serum Institute of India stockpiled about 40-50 million doses of the Covid-19 vaccine, taking a major risk.

Advertisement
• 

  'Absolute rubbish': DCGI on impotency rumours, says Covid vaccines 110% safe

  India | January 03, 2021 13:17 IST

  As India gears up for the world's largest vaccination programme, the Drugs Controller General of India (DCGI) on Sunday quelled rumours surrounding the COVID-19 vaccines regarding impotency, rubbishing such speculations as "absolute nonsense".

• 

  'Covishield' ready to roll out in coming weeks: Adar Poonawalla

  India | January 03, 2021 12:08 IST

  Poonawalla'' remarks came soon after after India's drugs regulator, Drug Controller General of India (DCGI) approved Covishield for restricted emergency use.

• 

  Vaccine shortage globally in first 6 months of 2021: Adar Poonawalla

  India | December 28, 2020 23:06 IST

  Serum Institute of India (SII) Chief Executive Officer Adar Poonawalla on Monday said that the world will see a shortage of the coronavirus vaccine in the first six months of 2021.

• 

  Govt must indemnify vaccine makers against all lawsuits: Adar Poonawalla

  India | December 20, 2020 8:24 IST

  "We need to have the government indemnify manufacturers, especially vaccine manufacturers, against all lawsuits. In fact, COVAX and other countries have already started talking about that," Poonawalla said.

• 

  COVID vaccination in India may start in January, expect normal life by Oct: Adar Poonawalla

  India | December 13, 2020 16:26 IST

  Serum Institute of India (SII) CEO Adar Poonawalla on Sunday said the COVID-19 vaccination drive in the country was likely to begin by January, in line with expectations of receiving approvals for emergency-use authorisation of Oxford-AstraZeneca vaccinate candidate by month-end.

• 

  Adar Poonawalla of Serum Institute of India among 6 ‘Asians of the Year’ named by Singapore daily

  Business | December 05, 2020 10:17 IST

  Pune-based Serum Institute of India (SII) has collaborated with the University of Oxford and the British-Swedish pharmaceutical company AstraZeneca for making the Covid-19 vaccine, ‘‘Covidshield’‘, and is conducting trials in India.

• 

  Serum Institute to apply for emergency-use authorisation of covishield in 2 weeks

  News | November 29, 2020 12:38 IST

  After holding a review meeting with Prime Minister Narendra Modi on Saturday, Serum Institute of India CEO Adar Poonawalla said that in the process of applying for emergency use authorization of Covishield in the next two weeks. He also said that there is an indication that the Centre may purchase 300-400 million doses by July 2021. "We are in the process of applying for emergency use authorization of Covishield in the next two weeks," Poonawala said.